國家衛生研究院 NHRI:Item 3990099045/13489
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 851089      在线人数 : 461
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于NHRI ‧ 管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/13489


    题名: Synergistic inhibition of SARS-CoV-2 replication using disulfiram/ebselen and remdesivir[Erratum:ACS Pharmacology and Translational Science. 2021 Apr 9;4(2):898-907.]
    其它题名: Correction to ";Synergistic Inhibition of SARS-CoV-2 Replication Using Disulfiram/Ebselen and Remdesivir"
    作者: Chen, T;Fei, CY;Chen, YP;Sargsyan, K;Liang, JJ;Liao, CC;Lin, YL;Chang, CP;Yuan, HS;Lim, C
    贡献者: Institute of Biotechnology and Pharmaceutical Research
    摘要: In the original manuscript, the authors Jian-Jong Liang, Chun-Che Liao, and Yi-Ling Lin were not listed. These three authors had performed the cell-based experiments in Figure 5b,c but were mistakenly listed in the acknowledgment section. The author list and affiliations should appear as in this Correction.
    日期: 2021-06-11
    關聯: ACS Pharmacology and Translational Science. 2021 Jun 11;4(3):Article number 1246.
    Link to: http://dx.doi.org/10.1021/acsptsci.1c00106
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85106586861
    显示于类别:[張竣評] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    PUB34136759.pdf568KbAdobe PDF88检视/开启


    在NHRI中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈